Effect of chemical stimulation of the medial frontal lobe on the micturition reflex in rats.

The Journal of urology 20120301

Benign prostatic hyperplasia: from bench to clinic.

Korean journal of urology 20120301

Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.

Biological & pharmaceutical bulletin 20120101

Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.

PloS one 20120101

How full is our antihypertensives pipeline?

Journal of pharmacology & pharmacotherapeutics 20120101

Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.

World journal of urology 20111201

Effects of Spinal and Peripheral Injection of α1A or α1D Adrenoceptor Antagonists on Bladder Activity in Rat Models with or without Bladder Outlet Obstruction.

International neurourology journal 20111201

Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.

International journal of radiation oncology, biology, physics 20111115

Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.

International journal of urology : official journal of the Japanese Urological Association 20111101

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

International neurourology journal 20110901

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.

BJU international 20110701

Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction.

BJU international 20110701

Clinical efficacy of a loading dose of naftopidil for patients with benign prostate hyperplasia.

World journal of urology 20110401

α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume.

World journal of urology 20110401

The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum.

World journal of urology 20110401

Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20110301

[Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].

Hinyokika kiyo. Acta urologica Japonica 20110201

An algorithm for medical management in male lower urinary tract symptoms.

Current opinion in urology 20110101

Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.

Cancer prevention research (Philadelphia, Pa.) 20110101

[Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication].

Hinyokika kiyo. Acta urologica Japonica 20110101

Clinical feature of men who benefit from dose escalation of naftopidil for lower urinary tract symptoms: a prospective study.

Advances in urology 20110101

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Clinical interventions in aging 20110101

Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia.

Therapeutics and clinical risk management 20110101

Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use.

International journal of nanomedicine 20110101

Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment.

International journal of molecular sciences 20110101

Re: Long-Term Treatment and Prognostic Factors of alpha1-Blockers for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Pilot Study Comparing Naftopidil and Tamsulosin Hydrochloride.

The Journal of urology 20110101

Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.

Scandinavian journal of urology and nephrology 20101201

Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cells.

Naunyn-Schmiedeberg's archives of pharmacology 20101201

[A randomized controlled study comparing clinical effects of naftopidil and tamsulosin on benign prostatic hyperplasia].

Hinyokika kiyo. Acta urologica Japonica 20100901

Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective study.

International journal of urology : official journal of the Japanese Urological Association 20100601

[Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].

Hinyokika kiyo. Acta urologica Japonica 20100401

[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].

Hinyokika kiyo. Acta urologica Japonica 20100401

Re: Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. X. Sun, L. He, W. Ge and J. Lv. J Urol 2009; 181: 1716-1720.

The Journal of urology 20100301

Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride.

Scandinavian journal of urology and nephrology 20100201

Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage.

The Journal of urology 20100101

A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.

Urologia internationalis 20100101

The add-on effect of solifenacin for patients with remaining overactive bladder after treatment with tamsulosin for lower urinary tract symptoms suggestive of benign prostatic obstruction.

Advances in urology 20100101

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.

The Cochrane database of systematic reviews 20091007

Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.

The Prostate 20091001

Mechanical function and gene expression of alpha(1)-adrenoceptor subtypes in dog intravesical ureter.

Urology 20090801

Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones.

The Journal of urology 20090401

[The clinical efficacy and safety of naftopidil 75 mg on benign prostatic hyperplasia patients with moderate or severe urinary disturbance].

Hinyokika kiyo. Acta urologica Japonica 20090401

1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.

ChemMedChem 20090301

Clinical efficacy of naftopidil on lower urinary tract symptoms after radical prostatectomy.

International journal of urology : official journal of the Japanese Urological Association 20090301

Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.

Neurourology and urodynamics 20090101

Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg.

Urologia internationalis 20090101

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.

Scandinavian journal of urology and nephrology 20090101

Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.

Urologia internationalis 20090101

Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study.

International journal of urology : official journal of the Japanese Urological Association 20081201

Alpha antagonists and intraoperative floppy iris syndrome: A spectrum.

Clinical ophthalmology (Auckland, N.Z.) 20081201

Effect of naftopidil on nocturia after failure of tamsulosin.

Urology 20081101

Alpha-adrenoceptor blockade modifies neurally induced atrial arrhythmias.

American journal of physiology. Regulatory, integrative and comparative physiology 20081001

[Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms].

Zhonghua nan ke xue = National journal of andrology 20081001

Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.

International journal of urology : official journal of the Japanese Urological Association 20080801

Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration.

Neurologia medico-chirurgica 20080501

[Evaluation of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia with persistent symptoms following treatment with alpha1-adrenoceptor blocker].

Hinyokika kiyo. Acta urologica Japonica 20080501

Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.

The Journal of urology 20080301

[Clinical evaluation of supplemental administration of flavoxate hydrochloride in benign prostatic hyperplasia patients with nocturia resistant to an alpha1-adrenoceptor blocker].

Hinyokika kiyo. Acta urologica Japonica 20080301

In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.

European journal of pharmacology 20080202

Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.

International journal of cancer 20080115

Differential effects of prazosin and naftopidil on pelvic blood flow and nitric oxide synthase levels in spontaneously hypertensive rats.

Journal of receptor and signal transduction research 20080101

Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats.

Neuroscience letters 20071218

Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.

The Prostate 20070901

[Comparison of different drugs on the treatment of benign prostate hyperplasia].

Zhonghua wai ke za zhi [Chinese journal of surgery] 20070715

[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia with overactive bladder].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20070701

[Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].

Yao xue xue bao = Acta pharmaceutica Sinica 20070701

Zinc(II) perchlorate hexahydrate catalyzed opening of epoxide ring by amines: applications to synthesis of (RS)/(R)-propranolols and (RS)/(R)/(S)-naftopidils.

The Journal of organic chemistry 20070511

[Giant prostate carcinoma treated effectively with endocrine therapy: case report].

Hinyokika kiyo. Acta urologica Japonica 20070201

Crossover comparison study on the therapeutic effects of tamsulosin hydrochloride and naftopidil in lower urinary tract symptoms associated with benign prostatic hyperplasia.

Drugs of today (Barcelona, Spain : 1998) 20070201

Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist.

American journal of ophthalmology 20070101

[The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].

Hinyokika kiyo. Acta urologica Japonica 20070101

Short-term efficacy and long-term compliance/treatment failure of the alpha1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Scandinavian journal of urology and nephrology 20070101

Search for new alpha1a-adrenoceptor-selective antagonist for treating lower urinary tract symptoms associated with benign prostatic hyperplasia.

Indian journal of urology : IJU : journal of the Urological Society of India 20070101

Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.

International journal of urology : official journal of the Japanese Urological Association 20061001

Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.

International journal of urology : official journal of the Japanese Urological Association 20061001

Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure.

European journal of pharmacology 20060918

[The study of the in vivo-in vitro correlation of the naftopidil sustained-release tablet in dog].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20060801

Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.

International journal of urology : official journal of the Japanese Urological Association 20060701

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.

BJU international 20060401

Emerging drug therapies for benign prostatic hyperplasia.

Expert opinion on emerging drugs 20060301

[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].